View Older Stories

Sep 8, 2026 07:50AM AstraZeneca COPD drug tozorakimab cuts exacerbations in Phase III trials

Sep 7, 2026 05:55PM FDA grants accelerated approval to AstraZeneca's camizestrant combo

Sep 4, 2026 03:41PM FDA approves AstraZeneca breast cancer drug Etcamah via accelerated path

Sep 1, 2026 06:09AM EU approves Enhertu combo for first-line HER2-positive breast cancer

Sep 1, 2026 06:09AM AstraZeneca acquires worldwide rights to lung cancer drug Zegfrovy

Sep 1, 2026 06:08AM AstraZeneca's Tagrisso combo shows Phase III benefit in lung cancer

Aug 27, 2026 06:04AM AstraZeneca's Tezspire meets endpoints in esophagitis trial

Aug 17, 2026 06:02AM AstraZeneca halts Phase III lung cancer trial after data review

Aug 17, 2026 06:02AM AstraZeneca's Tagrisso and Orpathys combo meets Phase III goals

Aug 12, 2026 12:04PM Morgan Stanley analysts visit National Resilience facility in Ohio, clients include LLY and AZN

Aug 5, 2026 08:31AM AZN spikes 6% after report it denies AstraZeneca-BMS merger talks

Aug 5, 2026 08:08AM 'No Discussions' Over Astrazeneca-Bristol Myers Deal, Senior Source Says - Reuters

Aug 4, 2026 06:15AM SOPHiA Genetics and AstraZeneca team up on two cancer diagnostics

Aug 3, 2026 11:24AM Bristol-Myers Squibb and AstraZeneca said to discuss megamerger - can it happen?

Aug 3, 2026 08:17AM AstraZeneca reviews potential Bristol Myers deal, Barclays comments

Aug 3, 2026 05:50AM AstraZeneca (AZN) call put ratio 1.7 calls to 1 put into share price lower before the bell

Aug 1, 2026 10:00PM Bernstein says risk-reward is positively skewed for this pharma stock

Jul 31, 2026 04:06AM EU approves AstraZeneca and Daiichi Sankyo's Datroway for breast cancer

Jul 27, 2026 08:59AM AstraZeneca says adjusting drug pricing over Trump policies

Jul 27, 2026 07:06AM AstraZeneca drug shows survival benefit in gastric cancer trial

Jul 27, 2026 06:14AM AstraZeneca (AZN) Tops Q2 EPS by 14c

Jul 27, 2026 06:06AM AstraZeneca's Ultomiris misses primary endpoint in adult HSCT-TMA trial

Jul 27, 2026 06:06AM AstraZeneca drug shows survival benefit in gastric cancer trial

Jul 26, 2026 08:00PM AstraZeneca (AZN) Q2 earnings preview

Jul 24, 2026 07:39AM Enhertu combination gets EU approval recommendation for breast cancer

Jul 24, 2026 06:50AM AstraZeneca's Trixeo receives EU recommendation for asthma treatment

Jul 14, 2026 06:55AM Alnylam Pharmaceuticals (ALNY) PT Raised to $485 at H.C. Wainwright

Jul 14, 2026 05:52AM AstraZeneca licenses sunvozertinib from Dizal for $600M upfront

Jul 13, 2026 07:06AM AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'

Jul 13, 2026 06:41AM BridgeBio Pharma (BBIO) PT Raised to $120 at H.C. Wainwright

Jul 13, 2026 02:24AM HSBC Downgrades AstraZeneca (AZN:LN) (AZN) to Hold

Jul 11, 2026 04:00AM Bernstein keeps telling clients to buy this pharma stock

Jul 10, 2026 09:00AM Buy the pullback in this major pharma stock: Bernstein

Jul 9, 2026 02:39PM AstraZeneca (AZN) call put ratio 1.9 calls to 1 put with a focus on July 180 and 190 calls

Jul 9, 2026 06:18AM AstraZeneca's Wainua fails primary endpoint in heart trial

Jul 2, 2026 03:20AM Abbisko and AstraZeneca to trial oral PD-L1 drug with Tagrisso

Jun 26, 2026 07:05AM AstraZeneca's Datroway recommended for EU approval in breast cancer

Jun 24, 2026 09:01AM AstraZeneca and YMCA of the USA form five-year cancer care deal

Jun 15, 2026 03:00AM AstraZeneca unit receives FDA priority review for rare kidney disease treatment

Jun 12, 2026 02:03PM AstraZeneca receives FDA approval for Truqap prostate cancer treatment

Jun 9, 2026 02:54AM BofA Securities Reiterates Buy Rating on AstraZeneca (AZN:LN) (AZN)

Jun 8, 2026 03:02AM AstraZeneca's Ultomiris shows 46.6% reduction in kidney protein levels

Jun 6, 2026 07:07AM Ultomiris shows 43% reduction in kidney protein levels in rare disease trial

Jun 2, 2026 08:02AM AstraZeneca reports positive SERENA-6 trial results for camizestrant

Jun 1, 2026 08:01AM AstraZeneca IMFINZI combo cuts liver cancer progression risk by 30%

May 28, 2026 12:42PM FDA Approves Durvalumab in Combination with Bacillus Calmette-Guerin for High-Risk Non-Muscle Invasive Bladder Cancer

May 27, 2026 04:04AM FDA extends review period for AstraZeneca breast cancer drug camizestrant

May 22, 2026 10:17AM DATROWAY approved in US for first-line metastatic triple-negative breast cancer

May 22, 2026 09:30AM Daiichi Sankyo gets US approval for Datroway in metastatic breast cancer

May 22, 2026 07:30AM AstraZeneca's camizestrant wins EU panel backing for breast cancer

View Older Stories